Purple Biotech Income Statement (2014-2026) | PPBT

Income Statement Sep2014 Dec2014 Sep2015 Dec2015 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
Operating items
Research & Development (Quarter)
2.09M1.62M4.87M5.95M2.08M3.46M4.82M3.50M3.71M4.59M5.24M3.42M2.39M1.35M0.46M0.76M0.55M0.59M1.83M1.23M
Selling, General & Administrative (Quarter)
1.53M1.42M2.91M1.38M1.51M1.62M1.78M1.62M1.43M1.16M1.02M1.04M0.86M0.79M0.56M0.65M0.68M0.78M1.14M1.02M
Other Operating Expenses (Quarter)
0.15M
Operating Expenses (Quarter)
3.62M3.20M7.78M7.33M3.59M5.08M6.60M5.12M5.13M5.75M6.27M4.47M3.26M2.13M1.02M1.41M1.24M1.37M2.96M2.25M
Operating Income (Quarter)
3.62M3.04M7.78M7.33M3.59M5.08M6.60M5.12M5.13M5.75M6.27M4.47M3.46M2.13M1.02M1.41M1.24M1.37M23.45M2.25M
EBIT (Quarter)
3.62M3.04M7.78M7.33M3.59M5.08M6.60M5.12M5.13M5.75M6.27M4.47M3.46M2.13M1.02M1.41M1.24M1.37M23.45M2.25M
Non-operating items
Non Operating Investment Income (Quarter)
-3.50M-0.95M-1.85M-0.08M0.06M
Interest & Investment Income (Quarter)
-0.08M-0.07M-0.12M-0.06M-0.09M-0.25M-0.58M-0.28M-0.12M-0.71M2.10M-0.10M-0.12M-0.13M-0.46M-0.05M-0.07M-0.12M-0.08M-0.02M
Other Non Operating Income (Quarter)
-3.50M
Non Operating Income (Quarter)
0.02M-0.05M-0.03M-0.01M-0.04M-0.23M-0.56M-0.22M0.03M-0.69M-1.41M-0.69M-1.04M-1.47M-0.60M-0.95M-0.15M-0.06M0.20M-2.16M
Net income details
EBT (Quarter)
3.44M2.95M7.57M7.23M3.45M4.82M6.04M4.79M4.86M5.02M6.28M4.35M3.31M1.49M0.63M1.32M1.22M1.24M23.15M2.20M
Profit After Tax (Quarter)
3.64M3.15M7.75M7.32M3.55M4.85M-6.04M4.79M4.86M5.02M-4.86M4.35M3.31M1.49M0.63M1.32M1.22M1.24M23.15M2.20M
Income from Non-Controlling Interests (Quarter)
0.02M0.01M0.05M0.02M0.02M0.03M0.03M0.03M0.02M0.02M0.03M0.02M0.01M0.01M0.01M0.00M0.00M0.00M0.10M0.00M
Income from Continuing Operations (Quarter)
3.44M2.95M7.57M7.23M3.45M4.82M6.04M4.79M4.86M5.02M6.28M4.35M3.31M1.49M0.63M1.32M1.22M1.24M23.15M2.20M
Consolidated Net Income (Quarter)
-0.00M0.15M0.51M7.23M3.45M4.82M6.04M4.79M4.86M5.02M6.28M4.35M3.31M1.49M0.63M1.32M1.22M1.24M23.15M2.20M
Income towards Parent Company (Quarter)
3.63M3.14M8.21M7.30M3.56M4.82M6.01M4.88M5.14M5.04M4.83M3.78M2.41M0.66M0.41M0.45M1.08M1.30M23.55M0.09M
Net Income towards Common Stockholders (Quarter)
3.64M3.15M8.21M7.30M3.56M4.82M6.01M4.88M5.14M5.04M4.83M3.78M2.41M0.66M0.41M0.45M1.08M1.30M23.55M0.09M
Additional items
EPS (Basic) (Quarter)
0.040.0493.4583.0740.4954.9266.4953.9756.8355.7043.6334.1321.795.992.502.766.627.950.020.00
EPS (Diluted) (Quarter)
0.040.040.090.080.040.0566.490.050.050.0543.630.030.090.022.500.000.020.0149.050.00
Shares Outstanding (Quarter)
87.27M87.56M0.09M0.09M0.09M0.09M0.09M0.09M0.09M0.09M0.11M0.11M0.11M0.11M0.16M0.16M0.16M0.16M960.11M960.11M
Shares Outstanding (Diluted) (Quarter)
86.89M86.89M88.40M89.06M89.06M89.06M0.09M99.19M99.19M99.19M0.11M135.57M27.53M34.65M0.16M263.23M54.72M91.10M0.48M930.68M
EBITDA (Quarter)
3.62M3.04M7.78M7.33M3.59M5.08M6.60M5.12M5.13M5.75M6.27M4.47M3.46M2.13M1.02M1.41M1.24M1.37M23.45M2.25M
Interest Expenses (Quarter)
0.10M0.02M0.09M0.04M0.05M0.02M-0.02M0.06M0.15M0.02M2.09M0.02M0.02M0.51M-0.07M0.04M-0.06M0.01M0.21M0.03M